For this review, the authors searched for randomized controlled trials published in MEDLINE, Embase, and Cochrane CENTRAL ...

A nationwide study confirms GLP-1 RAs pose no short-term psychiatric risk, showing a negative association with suicidal ...

An estimated 24 million Americans will use these weight loss drugs by 2035, posing significant challenges as well as ...

(Photo by: Michael Siluk/UCG/Universal Images Group via Getty Images) For those who are overweight or obese, medications known as glucagon-like peptide-1 agonists, or GLP-1s, have become very ...

Although GLP-1 medications may appear to be a solution for some people ... “This medication is targeted to the underlying ...

We all react to environmental cues that tell us it’s time to eat, like the scent of fries wafting through the air. These cues ...

Between Novo Nordisk's (NVO) slightly disappointing results for its latest GLP-1 candidate, CagriSema, and questions that remain about Amgen's (AMGN) highly anticipated once-monthly injectable ...

A recent study published in JAMA Network Open has revealed an unexpected connection between GLP-1 receptor agonist medications, commonly used for weight management, and a reduction in alcohol ...

People are reporting that their weight-loss medication helps them steer clear of drugs and alcohol. Studies are promising, but it may be too soon to celebrate.

With the explosion in popularity of diabetes and weight loss drugs like Ozempic and Zepbound, GLP-1 receptor agonist drugs have been hyped as potential miracle cures for many diseases. GLP-1s are ...

GLP-1 receptor agonists like Ozempic and Wegovy ... Martinelli wrote in an email to The Washington Post. “Medical physiology has only recently deepened the close connection that exists between ...